The Indian cohort study confirmed the association of CYP1A1rs1048943 with a lower risk of Prostate Cancer (Vijayalakshmi et al., 2005), this finding strongly suggests that CYP1A1 polymorphism may be closely linked to prostate cancer susceptibility (Wei et al., 2019). This evidence concerns the gene CYP1A1 and prostate carcinoma.